Skip to content

Tenet Healthcare THC Redeemable noncontrolling interests in subsidiaries

Redeemable noncontrolling interests in subsidiaries at other companies

Encompass Health Corporation logo
Encompass Health CorporationEHC
Healthpeak Properties logo
Healthpeak PropertiesDOC
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
Centene logo
CenteneCNC

Other financials

Income statement

See full
Revenue$5.4B+2.8%
Operating income$1.3B+37.4%
Net income$906.0M+45.7%
EPS (diluted)$8.01+87.6%

Balance sheet

See full
Cash & equivalents$3.0B-1.1%
Total debt$13.3B+0.2%
Total equity$4.8B+15.1%
Total assets$31.2B+6.7%

Cash flow

See full
Operating cash flow$1.6B+101%
CapEx$180.0M+4.0%
Free cash flow$1.5B+128%

Valuation

See full
Market cap$14.86B
Enterprise value$25.19B
P/E5.6×
P/S0.7×

Profitability

See full
Operating margin18%+0.4pp
Net margin12.4%+0.9pp
FCF margin15.6%

Returns & leverage

See full
Return on equity58.9%-2.7pp
Debt / equity2.8×-0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Tenet Healthcare in its filing.

Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount.

The official record: Tenet Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tenet Healthcare's redeemable noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tenet Healthcare's redeemable noncontrolling interests in subsidiaries?
Tenet Healthcare (THC) reported redeemable noncontrolling interests in subsidiaries of $2.14B in Q1 2026.
How has Tenet Healthcare's redeemable noncontrolling interests in subsidiaries changed year-over-year?
Tenet Healthcare's redeemable noncontrolling interests in subsidiaries decreased by 23.0% year-over-year, from $2.78B to $2.14B.
What is the long-term trend for Tenet Healthcare's redeemable noncontrolling interests in subsidiaries?
Over 4 years (2021 to 2025), Tenet Healthcare's redeemable noncontrolling interests in subsidiaries has grown at a 7.6% compound annual growth rate (CAGR), from $2.2B to $2.96B.